We are leading the way in developing green, enabling biotechnology and nanotechnology drug delivery platforms and enhanced therapeutic products for health maintenance, disease prevention and the treatment of certain cancers, infectious diseases and Central Nervous System (CNS) disorders such as Alzheimer's Disease. Aphios®, which means "virus-free" in Greek, was founded in 1993 as a Delaware C corporation. The company was founded by Dr. Trevor P. Castor, President and CEO, to develop enabling technology platforms around the delivery and viral safety of biologics such as human plasma and recombinant therapeutics, hence its "virus-free" name. At its founding, the Company elected to spend about 10% of its research activities on investigating natural therapeutics. This interest has evolved to the realization that in order to solve the problems of cancer and aging, we have to look to nature, marine organisms and terrestrial plants that have learned how to control cell growth and cancerous mutation, often living for hundreds to thousands of years.
Type
Private
HQ
Woburn, US
Founded
1993
Employees
8 (est)
Aphios was founded in 1993 and is headquartered in Woburn, US

Aphios Locations

Woburn, US

Aphios Metrics

Aphios Summary

Founding Date

1993

Total Funding

$2.4 M

Latest funding size

$2.4 M

Time since last funding

almost 5 years
Aphios's latest funding round of $2.4 M was in January 2012. In total, Aphios has raised $2.4 M.

Aphios Company Life

You may also be interested in